Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

The study, carried out by experts from the University of Nottingham and funded by the National Institute for Health Research ...

Long-term use of medication millions take every day has been linked to a significantly higher risk of dementia ...

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

Research out today is the latest to suggest that semaglutide can significantly lower people's risk of dementia.

She was taking 21 different prescription drugs, for diabetes, high blood pressure and her kidneys. After an assessment by a team that included a clinical pharmacy specialist well versed in drug ...

An analysis of 1.7 million patients shows semaglutide may significantly reduce Alzheimer and vascular dementia risk compared ...

While memory loss is commonly associated with dementia, research from the University of Chicago suggests that a significant ...

We know that a complex combination of factors contribute to Alzheimer's disease risk, including genetics, mental health, and ...

A massive U.S. study found diabetics on semaglutide (Ozempic’s active ingredient) had up to 70% lower risk of ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...